Maybe we could be better than Neuren -Neu, page-21

New to this thread but and stock and dont currently hold but am considering taking a position.

Have read the discussions and comparisons with Neuren and while I would love for another Aussie company to do well, one thing that worries me is the fact that this is a cannabis based product. I know the FDA has approved some but I feel like its a little like stem cells - there are factors at play that impact the success/availability of treatments like this one.

I could be totally wrong and am not down ramping or trying to 'diss' a competitor to Neuren (which I hold) - genuinely interested in this company but wondered if anyone else has had similar thoughts.